why choose us

First received: May 23, 2025

Clinical Trial: Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Yellow Fever Immunization

Study Type: INTERVENTIONAL


Official Title: A Phase 3 Randomized, Modified Double-blind, Active-controlled Study to Assess the Safety of vYF, Yellow Fever Vaccine, in Adults Aged 18 Years up to 60 Years

Brief Summary: The purpose of this study is to assess the safety of vYF (investigational vaccine) compared to the safety of YF-VAX (YF licensed vaccine) in adults aged 18 years up to 60 years.Study details include:The study duration will be up to approximately 6 months.One single dose of the study intervention (vYF or YF-VAX) will be administered subcutaneously at the 1st visit.The visit(V) frequency will be Day(D) 01 (V01) and D29 (V02).Two telephone calls will be planned at D15 and Month(M)6.Number of Participants:A total of…

Read more